241 related articles for article (PubMed ID: 35652307)
1. Comparative Transcriptomics Reveal Possible Mechanisms of Amphotericin B Resistance in Candida auris.
Shivarathri R; Jenull S; Chauhan M; Singh A; Mazumdar R; Chowdhary A; Kuchler K; Chauhan N
Antimicrob Agents Chemother; 2022 Jun; 66(6):e0227621. PubMed ID: 35652307
[TBL] [Abstract][Full Text] [Related]
2. The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris.
Shivarathri R; Jenull S; Stoiber A; Chauhan M; Mazumdar R; Singh A; Nogueira F; Kuchler K; Chowdhary A; Chauhan N
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055262
[No Abstract] [Full Text] [Related]
3. Transcriptomics and Phenotyping Define Genetic Signatures Associated with Echinocandin Resistance in Candida auris.
Jenull S; Shivarathri R; Tsymala I; Penninger P; Trinh PC; Nogueira F; Chauhan M; Singh A; Petryshyn A; Stoiber A; Chowdhary A; Chauhan N; Kuchler K
mBio; 2022 Aug; 13(4):e0079922. PubMed ID: 35968956
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs.
Ben Abid F; Salah H; Sundararaju S; Dalil L; Abdelwahab AH; Salameh S; Ibrahim EB; Almaslmani MA; Tang P; Perez-Lopez A; Tsui CKM
Clin Microbiol Infect; 2023 Aug; 29(8):1083.e1-1083.e7. PubMed ID: 37116861
[TBL] [Abstract][Full Text] [Related]
5. Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation.
Siopi M; Peroukidou I; Beredaki MI; Spruijtenburg B; de Groot T; Meis JF; Vrioni G; Tsakris A; Pournaras S; Meletiadis J
Microbiol Spectr; 2023 Jun; 11(3):e0443122. PubMed ID: 37036351
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of in vivo-evolved Candida auris reveals multidrug-resistance mechanisms.
Chen XF; Zhang H; Liu LL; Guo LN; Liu WJ; Liu YL; Li DD; Zhao Y; Zhu RY; Li Y; Dai RC; Yu SY; Li J; Wang T; Dou HT; Xu YC
Mycopathologia; 2024 Apr; 189(3):35. PubMed ID: 38637433
[TBL] [Abstract][Full Text] [Related]
7.
O'Brien B; Chaturvedi S; Chaturvedi V
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
[TBL] [Abstract][Full Text] [Related]
8. In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris.
Rybak JM; Barker KS; Muñoz JF; Parker JE; Ahmad S; Mokaddas E; Abdullah A; Elhagracy RS; Kelly SL; Cuomo CA; Rogers PD
Clin Microbiol Infect; 2022 Jun; 28(6):838-843. PubMed ID: 34915074
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant
Salama EA; Elgammal Y; Wijeratne A; Lanman NA; Utturkar SM; Farhangian A; Li J; Meunier B; Hazbun TR; Seleem MN
Emerg Microbes Infect; 2024 Dec; 13(1):2322649. PubMed ID: 38431850
[No Abstract] [Full Text] [Related]
10. The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris.
Rybak JM; Cuomo CA; Rogers PD
Curr Opin Microbiol; 2022 Dec; 70():102208. PubMed ID: 36242897
[TBL] [Abstract][Full Text] [Related]
11. The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.
Mesa-Arango AC; Trevijano-Contador N; Román E; Sánchez-Fresneda R; Casas C; Herrero E; Argüelles JC; Pla J; Cuenca-Estrella M; Zaragoza O
Antimicrob Agents Chemother; 2014 Nov; 58(11):6627-38. PubMed ID: 25155595
[TBL] [Abstract][Full Text] [Related]
12. Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance.
Escandón P; Chow NA; Caceres DH; Gade L; Berkow EL; Armstrong P; Rivera S; Misas E; Duarte C; Moulton-Meissner H; Welsh RM; Parra C; Pescador LA; Villalobos N; Salcedo S; Berrio I; Varón C; Espinosa-Bode A; Lockhart SR; Jackson BR; Litvintseva AP; Beltran M; Chiller TM
Clin Infect Dis; 2019 Jan; 68(1):15-21. PubMed ID: 29788045
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characterization and Sterol Profiles Identify Nonsynonymous Mutations in
Asadzadeh M; Alfouzan W; Parker JE; Meis JF; Kelly SL; Joseph L; Ahmad S
Microbiol Spectr; 2023 Aug; 11(4):e0147423. PubMed ID: 37358415
[TBL] [Abstract][Full Text] [Related]
14. Unmasking the Amphotericin B Resistance Mechanisms in
Silva LN; Oliveira SSC; Magalhães LB; Andrade Neto VV; Torres-Santos EC; Carvalho MDC; Pereira MD; Branquinha MH; Santos ALS
ACS Infect Dis; 2020 May; 6(5):1273-1282. PubMed ID: 32239912
[TBL] [Abstract][Full Text] [Related]
15. Upc2-mediated mechanisms of azole resistance in
Li J; Aubry L; Brandalise D; Coste AT; Sanglard D; Lamoth F
Microbiol Spectr; 2024 Feb; 12(2):e0352623. PubMed ID: 38206035
[No Abstract] [Full Text] [Related]
16. Defining Optimal Doses of Liposomal Amphotericin B Against Candida auris: Data From an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Beredaki MI; Sanidopoulos I; Pournaras S; Meletiadis J
J Infect Dis; 2024 Feb; 229(2):599-607. PubMed ID: 38109276
[TBL] [Abstract][Full Text] [Related]
17. The sphingolipid inhibitor myriocin increases Candida auris susceptibility to amphotericin B.
Stieber H; Junghanns L; Wilhelm H; Batliner M; Aldejohann AM; Kurzai O; Martin R
Mycoses; 2024 Apr; 67(4):e13723. PubMed ID: 38551121
[TBL] [Abstract][Full Text] [Related]
18. Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods.
Shin JH; Kim MN; Jang SJ; Ju MY; Kim SH; Shin MG; Suh SP; Ryang DW
J Clin Microbiol; 2012 Jun; 50(6):1852-5. PubMed ID: 22442324
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipidomics of drug resistant Candida auris clinical isolates reveal distinct sphingolipid species signatures.
Kumar M; Singh A; Kumari S; Kumar P; Wasi M; Mondal AK; Rudramurthy SM; Chakrabarti A; Gaur NA; Gow NAR; Prasad R
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158815. PubMed ID: 32942047
[TBL] [Abstract][Full Text] [Related]
20. Induction of amphotericin B resistance in susceptible
Chan W; Chow FW; Tsang CC; Liu X; Yao W; Chan TT; Siu GK; Ho AY; Luk KS; Lau SK; Woo PC
Emerg Microbes Infect; 2022 Dec; 11(1):1900-1909. PubMed ID: 35786393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
